News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2024 Shelley Wood March 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show Yael L. Maxwell January 10, 2024
News Daily News COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021 Todd Neale January 09, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Conference News AHA 2023 Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3 Shelley Wood November 11, 2023
News Conference News TCT 2023 SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC Yael L. Maxwell October 30, 2023
Presentation TCT 2023 TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy Presenter: Said hajouli October 26, 2023
News Daily News Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis L.A. McKeown September 25, 2023
News Daily News Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival L.A. McKeown September 14, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023